WHO ICTRP trial
A clinical trial to test if RLY5016 is safe and can lower high blood potassium…
EUCTR2011-000165-12-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2011-000165-12-HU |
|---|---|
| Public title | A clinical trial to test if RLY5016 is safe and can lower high blood potassium levels in patients with high blood pressure and kidney disease due to diabetes who are also taking standard medications for their disease. |
| Scientific title | A Multicenter, Randomized, Open-Label, Dose Ranging Study to Evaluate the Efficacy and Safety of RLY5016 in the Treatment of Hyperkalemia in Patients with Hypertension and Diabetic Nephropathy Receiving ACEI and/or ARB Drugs, with or without Spironolactone - AMETHYST-DN |
| Primary sponsor | Relypsa, Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Serbia;Hungary;Slovenia;Croatia;Austria;Georgia;Germany |
| Conditions | Hyperkalemia in Patients with Hypertension and Diabetic Nephropathy MedDRA version: 13.1 Level: PT Classification code 10020772 Term: Hypertension System Organ Class: 10047065 - Vascular disorders MedDRA version: 13.1 Level: LLT… |
| Interventions | Product Name: RLY5016 powder for suspension Product Code: RLY5016 Pharmaceutical Form: Powder for oral suspension CAS Number: 1208912-84-8 Current Sponsor code: RLY5016S Concentration unit: g gram(s) Concentration type: equal Concentration… |
| Registration date | Mar 29, 2011 |
| Target size | 150 |
| Secondary IDs | RLY5016-205 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: